18 July 2025 in Scientific Reports
We aimed to describe lung ultrasound (LUS) findings in COVID-19 pneumonia and to analyze the association with initial severity and outcome. Prospective cohort study among intensive care unit (ICU) patients in a teaching hospital in Tunisia. A 20-bed respiratory medical intensive care unit of Abderrahmen Mami Teaching Hospital from January to December 2021. We included all COVID-19 pneumonia patients managed in ICU. LUS examination and chest computed tomography (CT), when possible, were performed during the first 24 h of ICU stay. LUS findings were described and association with severity was analysed for trends. During the one-year study period, 311 patients were included with a median age of 58 IQR [47–67] years. ARDS was diagnosed in 307 patients (98.7%). Median initial PaO2/FiO2 was 112 IQR [81–157] mmHg. Median length of stay was 10 IQR [7–14] days and overall mortality was of 45.3%. Median LUS score was 29 IQR [25–32]. LUS score gradients were apico-basal and postero-antero-lateral. There was a significant correlation between ROX index and LUS score with r= -0.146 and p = 0.013. LUS score above 25 was significantly associated with chest CT damage exceeding 75% (NPV = 80.7%). LUS score under 25 was significantly associated with chest CT damage < 50% (NPV = 77.5%). No association was found between the LUS score and mortality or the need for invasive ventilation. In COVID-19 pneumonia, LUS is a good and safe tool for initial severity assessment. LUS score is correlated with ROX index and extent of chest damage on CT scan. However, LUS score does not predict outcome nor need for invasive mechanical ventilation.
20 December 2023 in Influenza and Other Respiratory Viruses
Background: We compared patients diagnosed at a SARI (severe acute respiratory infections) surveillance site with COVID‐19 and those with seasonal influenza to investigate the clinical differences, common features, and outcomes.Methods: We conducted a descriptive, retrospective study in the Medical Intensive Care Unit (ICU) at Abderrahman Mami Hospital between September 2021 and April 2022. Demographic, clinical, and biological data as well as outcomes were recorded for all patients.Results: Among 223 SARI patients, 83 were confirmed COVID‐19, and 22 were influenza positive. The distribution according to gender was similar; but patients with influenza were younger than those suffering from COVID‐19(mean age 60.36 SD 17.28 vs. 61.88 SD 17.91; P = 0.601). In terms of underlying chronic diseases, the frequency was 84.3% in the COVID‐19 group and 72.7% in the influenza group. COVID‐19 patients had a longer duration of hospitalization (mean [SD], 9.51 days [8.47 days] vs. 7.33 days [8.82 days]; P = 0.003), and a more frequent need for invasive ventilation (80 [97.4%] vs. 20 [92.3]). Case fatality was also higher among this group compared to the latter (39 [47%] vs. 6 [27.3%], P = 0.01).Conclusion: This exploratory study suggests higher severity of COVID‐19 compared to seasonal influenza among SARI hospitalized patients even during the Omicron wave. Further research on higher sample sizes is required to confirm this conclusion.
1 October 2026 in The Egyptian Journal of Critical Care Medicine
Introduction: Awake prone positioning (APP) has been widely used in patients with COVID-19-related acute respiratory distress syndrome (ARDS), but its effectiveness may vary depending on the oxygenation interface. This study aimed to compare the response to APP according to different oxygenation interfaces and to identify predictors of response. Methods: We conducted a prospective observational study including adult patients admitted to the intensive care unit for severe to critical COVID-19, from March to May 2021. APP sessions of at least 30 min were performed within the first 24 h using conventional oxygen therapy (COT), high-flow nasal oxygen (HFNO), and noninvasive ventilation (NIV), applied sequentially when tolerated. Arterial blood gases were measured before and 20 min after each session. Response was defined as an increase of ≥ 20% in the PaO₂/FiO₂ ratio. Results: Fifty-six patients were included. Response rates differed across interfaces: 25.5% under COT, 34.4% under HFNO, and 43.9% under NIV. Responders under COT and HFNO had lower intubation rates ( p = 0.03 and p = 0.01, respectively), and responders under HFNO had shorter hospital stays ( p = 0.018). Mortality was higher among non-responders for all interfaces except NIV ( p = 0.6). Higher body mass index (BMI) was associated with response under COT and HFNO, with ROC analysis identifying a predictive cutoff between 27.3 and 28.3 kg/m². Conclusions: The response to APP differs according to the oxygenation interface. APP response may be associated with improved clinical outcomes, particularly under COT and HFNO. Higher BMI appears to predict a favorable response. These findings should be interpreted cautiously given the observational design and sequential application of interfaces.
1 June 2017 in Medecine Et Maladies Infectieuses